MESONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as MEOBF
MESOBLAST LTD
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Aug 27, 2026
$11.95−1.33 (-10.02%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
4M
Shares held, 13F filers
Institutional holders
71
9 new, 6 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
30 buys · 0 sales
Net bought $37.53M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Gueck William J. | 64,521,900 | 5.00% | 13G (passive) | Sep 12, 2025 |
| George, Gregory | 288,522,256 | 22.36% | 13G (passive) amendment | Mar 6, 2026 |
| Gregory George | 275,851,734 | 21.59% | 13G (passive) amendment | Sep 11, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of MESO | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Morgan Stanley | 718,608 | – | $9.72M | +204,177 | 0.00% |
| BlackRock, Inc. | 664,280 | – | $8.99M | +33,425 | 0.00% |
| Susquehanna International Group, Llp | 457,744 | – | $6.19M | +71,272 | 0.00% |
| Goldman Sachs Group Inc | 395,612 | – | $5.35M | −1,603 | 0.00% |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 259,700 | – | $3.51M | New | 0.00% |
| UBS Group AG | 200,053 | – | $2.71M | +67,480 | 0.00% |
| SRS Capital Advisors, Inc. | 168,022 | – | $2.27M | +143,597 | 0.02% |
| Bank Of America Corp /De/ | 100,000 | – | $1.35M | −4 | 0.00% |
| Penbrook Management LLC | 87,075 | – | $1.18M | – | 0.75% |
| M&g PLC | 59,100 | – | $827.40K | – | 0.00% |
| Quadrature Capital Ltd | 53,126 | – | $718.80K | +35,879 | 0.01% |
| LPL Financial LLC | 47,867 | – | $647.64K | −1,750 | 0.00% |
| Lazari Capital Management, Inc. | 47,421 | – | $641.61K | +1,300 | 0.20% |
| Rialto Wealth Management, LLC | 46,500 | – | $629.15K | – | 0.12% |
| Group One Trading, L.P. | 44,030 | – | $595.73K | −39,885 | 0.00% |
| Royal Bank of Canada | 44,003 | – | $595.00K | +17,737 | 0.00% |
| Two Sigma Investments, LP | 43,403 | – | $587.24K | +3,601 | 0.00% |
| Geode Capital Management, LLC | 33,747 | – | $456.60K | – | 0.00% |
| Jane Street Group, LLC | 33,152 | – | $448.55K | −65,634 | 0.00% |
| &partners | 27,567 | – | $372.98K | +621 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 71 | 4M | 9 / 24 | 20 / 6 | 1M | 0M |
| Q1 2026 | 69 | 3M | 9 / 25 | 17 / 13 | 0M | 1M |
| Q4 2025 | 74 | 4M | 14 / 24 | 21 / 7 | 1M | 0M |
| Q3 2025 | 67 | 4M | 13 / 21 | 19 / 17 | 1M | 1M |
| Q2 2025 | 71 | 4M | 15 / 19 | 21 / 11 | 1M | 1M |
| Q1 2025 | 68 | 4M | 17 / 24 | 15 / 10 | 2M | 1M |
| Q4 2024 | 61 | 3M | 26 / 21 | 6 / 8 | 2M | 0M |
| Q3 2024 | 43 | 2M | 10 / 13 | 11 / 4 | 0M | 0M |
| Q2 2024 | 39 | 1M | 17 / 12 | 4 / 3 | 1M | 0M |
| Q1 2024 | 26 | 1M | 24 / 1 | 1 / 0 | 1M | 0M |
| Q4 2023 | 2 | 0M | 2 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of MESO | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Biotechnology ETF | 495,405 | – | $6.70M | 0.07% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 33,747 | – | $519.70K | 0.00% | May 31, 2026 |
| Steward Values Enhanced International Fund | 6,507 | – | $92.20K | 0.03% | Jul 31, 2026 |
| ActivePassive International Equity ETF | 6,319 | – | $97.31K | 0.01% | May 31, 2026 |
| Invesco Nasdaq Biotechnology ETF | 2,767 | – | $42.61K | 0.06% | May 31, 2026 |
| ProShares Ultra Nasdaq Biotechnology | 1,934 | – | $29.78K | 0.04% | May 31, 2026 |
| Blackstone Alternative Multi-Strategy Fund | -100 | – | -$1.35K | -0.00% | Jun 30, 2026 |
| Multi-Manager Directional Alternative Strategies Fund | -6,514 | – | -$92.30K | -0.03% | Jul 31, 2026 |
| Boston Partners Long/Short Research Fund | -28,324 | – | -$436.19K | -0.07% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Silviu Itescu | CEO and Managing Director | 78,958,928 | Apr 1, 2026 |
| Eric Allen Rose | Chief Medical Officer,Director | 714,720 | Mar 18, 2026 |
| James Michael Obrien | Chief Financial Officer | – | Jul 9, 2026 |
| Lynette Elizabeth Cobley | Director | 63,000 | Apr 29, 2026 |
| Gregory George | Director, 10% owner | 162,154,002 | Apr 13, 2026 |
| William Murray Burns | Director | 226,250 | Apr 1, 2026 |
| Philip James Facchina | Director | 123,220 | Mar 18, 2026 |
| Jane Catherine Bell | Director | 622,492 | Mar 18, 2026 |
| Philip R. Krause | Director | 287,500 | Mar 18, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Gregory George Director, 10% owner | Apr 10, 2026 | Buy | +2,324,072 | $1.48 | $3.44M | 8,324,072 |
| Gregory George Director, 10% owner | Apr 10, 2026 | Buy | +2,324,072 | $1.48 | $3.44M | 8,324,072 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +10,000 | $1.43 | $14.30K | 13,536,650 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +20,000 | $1.43 | $28.60K | 13,526,650 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +4,760 | $1.44 | $6.85K | 13,506,650 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +5,240 | $1.43 | $7.49K | 13,541,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +886,890 | $1.43 | $1.27M | 12,886,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +105,000 | $1.46 | $153.30K | 12,991,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +500,000 | $1.44 | $720.00K | 13,491,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +10,000 | $1.44 | $14.40K | 13,501,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +10,000 | $1.41 | $14.10K | 13,586,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +10,000 | $1.43 | $14.30K | 13,576,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +10,000 | $1.43 | $14.30K | 13,566,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +5,000 | $1.43 | $7.15K | 13,556,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +10,000 | $1.43 | $14.30K | 13,551,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +10,000 | $14.40 | $144.00K | 13,501,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +4,760 | $14.40 | $68.54K | 13,506,650 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +20,000 | $14.30 | $286.00K | 13,526,650 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +10,000 | $14.30 | $143.00K | 13,536,650 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +5,240 | $14.25 | $74.67K | 13,541,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +10,000 | $14.25 | $142.50K | 13,551,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +5,000 | $14.30 | $71.50K | 13,556,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +10,000 | $14.30 | $143.00K | 13,566,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +10,000 | $14.30 | $143.00K | 13,576,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +500,000 | $14.39 | $7.20M | 13,491,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +500,000 | $14.39 | $7.20M | 13,491,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +886,890 | $1.43 | $1.27M | 12,886,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +10,000 | $14.10 | $141.00K | 13,586,890 |
| Gregory George Director, 10% owner | Apr 4, 2026 | Buy | +4,000,000 | $1.42 | $5.68M | 12,000,000 |
| Gregory George Director, 10% owner | Apr 4, 2026 | Buy | +4,000,000 | $1.42 | $5.68M | 12,000,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.